Attached files
Exhibit
32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with this Annual Report on Form 10-K of Peak
Pharmaceuticals, Inc. (the “Company”) for the period
ended September 30, 2016 as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), the
undersigned, in the capacity and on the date indicated below,
hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to
his knowledge:
1.
|
The
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
|
|
|
2.
|
The
information contained in the Report fairly presents, in all
material respects, the financial condition and results of operation
of the Company.
|
Date:
|
|
September
12, 2017
|
|
|
|
By:
|
|
/s/
Neil Reithinger
|
Name:
|
|
Neil
Reithinger
|
Title:
|
|
Chief
Financial Officer
(Principal
Financial Officer and Principal Accounting Officer)
|